Clinical Trial Update: PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating PET-adjusted intensity-modulated radiation therapy with combination chemotherapy in stage II-IV non-small cell lung cancer; study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasm in the Brain
• Non-small Cell Lung Cancer

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Metastatic Malignant Neoplasm in the Brain, Recurrent Non-Small Cell Lung Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2020-01-22